Independent prognostic value of screen detection in invasive breast cancer (Q51053686)

27 March 2018

title

Independent prognostic value of screen detection in invasive breast cancer (English)

1 reference

27 March 2018

author

Marjanka K Schmidt

8

1 reference

27 March 2018

Emiel Rutgers

3

object named as

Emiel J Rutgers

1 reference

27 March 2018

Flora E. van Leeuwen

6

object named as

Flora E van Leeuwen

1 reference

27 March 2018

Otto Visser

7

object named as

Otto Visser

1 reference

27 March 2018

author name string

Stella Mook

1

1 reference

27 March 2018

Laura J Van 't Veer

2

1 reference

27 March 2018

Peter M Ravdin

4

1 reference

27 March 2018

Anthonie O van de Velde

5

1 reference

27 March 2018

language of work or name

English

0 references

publication date

24 February 2011

1 reference

27 March 2018

Journal of the National Cancer Institute

published in

1 reference

27 March 2018

volume

103

1 reference

27 March 2018

issue

7

1 reference

27 March 2018

page(s)

585-597

1 reference

27 March 2018

Why is breast-cancer mortality declining?

cites work

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Trends in breast cancer by race and ethnicity: update 2006.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Mammographic screening: evidence from randomised controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Risk for distant recurrence of breast cancer detected by mammography screening or other methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Improved breast cancer survival following introduction of an organized mammography screening program among both screened and unscreened women: a population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Role of detection method in predicting breast cancer survival: analysis of randomized screening trials.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Stage-shift cancer screening model

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Breast cancers found by screening: earlier detection, lower malignant potential or both?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Lead time in breast cancer detection and implications for periodicity of screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Screen-detected vs symptomatic breast cancer: is improved survival due to stage migration alone?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Calibration and discriminatory accuracy of prognosis calculation for breast cancer with the online Adjuvant! program: a hospital-based retrospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Population-based validation of the prognostic model ADJUVANT! for early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Computer program to assist in making decisions about adjuvant therapy for women with early breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Nation-wide breast cancer screening in The Netherlands: results of initial and subsequent screening 1990-1995. National Evaluation Team for Breast Cancer Screening.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Histological grading and prognosis in breast cancer; a study of 1409 cases of which 359 have been followed for 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Cancer survival in five continents: a worldwide population-based study (CONCORD).

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Community-based use of chemotherapy and hormonal therapy for early-stage breast cancer: 1987-2000.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Breast carcinoma survival in Europe and the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Overdiagnosis in publicly organised mammography screening programmes: systematic review of incidence trends

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Rethinking screening for breast cancer and prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

The natural history of invasive breast cancers detected by screening mammography

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Effect of screening and adjuvant therapy on mortality from breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

A study of interval breast cancer within the NHS breast screening programme

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Interval breast cancers are not biologically distinct--just more difficult to diagnose

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

All-cause mortality in randomized trials of cancer screening

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Gene expression profiling predicts clinical outcome of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

Should Screen-detected Breast Cancers Be Managed Differently?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FJNCI%2FDJR043

21 January 2018

Identifiers

DOI

10.1093/JNCI/DJR043

1 reference

27 March 2018

1 reference

27 March 2018